Go Pro
→ Elon’s AI Phone is coming (From Stansberry Research) (Ad)tc pixel Free AVR Stock Alerts

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$7.62 -0.51 (-6.27%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$7.65 +0.03 (+0.41%)
As of 06:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

AVR vs. TMDX, ATRC, AXGN, INSP, and BFLY

Should you buy Anteris Technologies Global stock or one of its competitors? Anteris Technologies Global's main competitors and comparable companies include TransMedics Group (TMDX), AtriCure (ATRC), AxoGen (AXGN), Inspire Medical Systems (INSP), and Butterfly Network (BFLY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Anteris Technologies Global compare to TransMedics Group?

Anteris Technologies Global (NASDAQ:AVR) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

TransMedics Group has a net margin of 22.69% compared to Anteris Technologies Global's net margin of -4,619.27%. TransMedics Group's return on equity of 15.88% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies Global-4,619.27% -77.69% -67.99%
TransMedics Group 22.69%15.88%5.95%

In the previous week, Anteris Technologies Global and Anteris Technologies Global both had 3 articles in the media. Anteris Technologies Global's average media sentiment score of 0.70 beat TransMedics Group's score of 0.22 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anteris Technologies Global
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TransMedics Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Anteris Technologies Global has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

TransMedics Group has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$1.91M388.82-$94.14M-$1.95N/A
TransMedics Group$668.47M4.50$190.29M$3.8922.37

99.7% of TransMedics Group shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Anteris Technologies Global presently has a consensus price target of $16.00, indicating a potential upside of 109.97%. TransMedics Group has a consensus price target of $121.10, indicating a potential upside of 39.20%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
TransMedics Group
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

TransMedics Group beats Anteris Technologies Global on 11 of the 15 factors compared between the two stocks.

How does Anteris Technologies Global compare to AtriCure?

Anteris Technologies Global (NASDAQ:AVR) and AtriCure (NASDAQ:ATRC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

99.1% of AtriCure shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by insiders. Comparatively, 4.0% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Anteris Technologies Global has a beta of 1.8, indicating that its share price is 80% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Anteris Technologies Global presently has a consensus price target of $16.00, suggesting a potential upside of 109.97%. AtriCure has a consensus price target of $53.30, suggesting a potential downside of 11.11%. Given Anteris Technologies Global's higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than AtriCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
AtriCure
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, Anteris Technologies Global had 1 more articles in the media than AtriCure. MarketBeat recorded 3 mentions for Anteris Technologies Global and 2 mentions for AtriCure. Anteris Technologies Global's average media sentiment score of 0.70 beat AtriCure's score of 0.42 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anteris Technologies Global
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AtriCure
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

AtriCure has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$1.91M388.82-$94.14M-$1.95N/A
AtriCure$534.53M5.71-$11.45M$0.21285.52

AtriCure has a net margin of 1.85% compared to Anteris Technologies Global's net margin of -4,619.27%. AtriCure's return on equity of 2.34% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies Global-4,619.27% -77.69% -67.99%
AtriCure 1.85%2.34%1.77%

Summary

AtriCure beats Anteris Technologies Global on 11 of the 17 factors compared between the two stocks.

How does Anteris Technologies Global compare to AxoGen?

Anteris Technologies Global (NASDAQ:AVR) and AxoGen (NASDAQ:AXGN) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.

Anteris Technologies Global has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market.

In the previous week, Anteris Technologies Global had 1 more articles in the media than AxoGen. MarketBeat recorded 3 mentions for Anteris Technologies Global and 2 mentions for AxoGen. Anteris Technologies Global's average media sentiment score of 0.70 beat AxoGen's score of 0.51 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anteris Technologies Global
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AxoGen
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Anteris Technologies Global currently has a consensus target price of $16.00, indicating a potential upside of 109.97%. AxoGen has a consensus target price of $51.56, indicating a potential upside of 19.01%. Given Anteris Technologies Global's higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
AxoGen
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

AxoGen has a net margin of -13.36% compared to Anteris Technologies Global's net margin of -4,619.27%. AxoGen's return on equity of -8.90% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies Global-4,619.27% -77.69% -67.99%
AxoGen -13.36%-8.90%-6.47%

80.3% of AxoGen shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

AxoGen has higher revenue and earnings than Anteris Technologies Global. AxoGen is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$1.91M388.82-$94.14M-$1.95N/A
AxoGen$225.21M10.34-$15.70M-$0.68N/A

Summary

AxoGen beats Anteris Technologies Global on 9 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Inspire Medical Systems has a net margin of 15.03% compared to Anteris Technologies Global's net margin of -4,619.27%. Inspire Medical Systems' return on equity of 8.64% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Anteris Technologies Global -4,619.27%-77.69%-67.99%

Inspire Medical Systems currently has a consensus target price of $66.50, suggesting a potential downside of 3.72%. Anteris Technologies Global has a consensus target price of $16.00, suggesting a potential upside of 109.97%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inspire Medical Systems has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.8, meaning that its stock price is 80% more volatile than the broader market.

Inspire Medical Systems has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$898.74M2.22$145.42M$4.6214.95
Anteris Technologies Global$1.91M388.82-$94.14M-$1.95N/A

In the previous week, Inspire Medical Systems had 2 more articles in the media than Anteris Technologies Global. MarketBeat recorded 5 mentions for Inspire Medical Systems and 3 mentions for Anteris Technologies Global. Inspire Medical Systems' average media sentiment score of 1.64 beat Anteris Technologies Global's score of 0.70 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Anteris Technologies Global
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inspire Medical Systems beats Anteris Technologies Global on 11 of the 17 factors compared between the two stocks.

How does Anteris Technologies Global compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Butterfly Network has a net margin of -66.74% compared to Anteris Technologies Global's net margin of -4,619.27%. Butterfly Network's return on equity of -33.99% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-66.74% -33.99% -22.96%
Anteris Technologies Global -4,619.27%-77.69%-67.99%

Butterfly Network has higher revenue and earnings than Anteris Technologies Global. Butterfly Network is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$112.14M21.92-$77.06M-$0.29N/A
Anteris Technologies Global$1.91M388.82-$94.14M-$1.95N/A

37.8% of Butterfly Network shares are held by institutional investors. 22.0% of Butterfly Network shares are held by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Butterfly Network had 4 more articles in the media than Anteris Technologies Global. MarketBeat recorded 7 mentions for Butterfly Network and 3 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 0.70 beat Butterfly Network's score of 0.41 indicating that Anteris Technologies Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
1 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Anteris Technologies Global
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Butterfly Network currently has a consensus price target of $7.25, indicating a potential downside of 21.47%. Anteris Technologies Global has a consensus price target of $16.00, indicating a potential upside of 109.97%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Anteris Technologies Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Butterfly Network has a beta of 2.08, meaning that its share price is 108% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market.

Summary

Butterfly Network beats Anteris Technologies Global on 10 of the 15 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

Export
MetricAnteris Technologies GlobalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$792.34M$5.58B$7.31B$13.29B
Dividend YieldN/A1.79%2.52%12.57%
P/E Ratio-3.9125.26274.0825.69
Price / Sales388.8271.56638.2178.99
Price / CashN/A33.0277.8052.76
Price / Book-762.005.7810.476.32
Net Income-$94.14M$151.55M$3.49B$359.73M
7 Day Performance-9.50%-0.01%-0.67%0.17%
1 Month Performance-13.41%-3.53%-3.17%-3.27%
1 Year Performance72.01%6.37%15.14%5.58%

Anteris Technologies Global Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
2.5277 of 5 stars		$7.62
-6.3%		$16.00
+110.0%		+59.1%$792.34M$1.91MN/A174
TMDX
TransMedics Group
4.3116 of 5 stars		$87.29
+1.0%		$121.10
+38.7%		-27.8%$2.99B$605.49M22.44898
ATRC
AtriCure
2.0886 of 5 stars		$58.32
+0.4%		$53.30
-8.6%		+63.6%$2.96B$534.53M277.731,350
AXGN
AxoGen
2.4848 of 5 stars		$45.93
+3.8%		$51.56
+12.2%		+150.4%$2.38B$225.21MN/A622
INSP
Inspire Medical Systems
3.3502 of 5 stars		$75.35
-1.9%		$66.50
-11.7%		-10.3%$2.22B$911.98M16.311,333

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AVR) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
On October 7th, your “safest” assets are at risk
Jeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...
Brownstone Research | Sponsoredtc pixel
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
Everyone remembers January's silver spike. Then what?
Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...
i2i Marketing Group, LLC | Sponsoredtc pixel